VSee Health (VSEE)
NASDAQ:VSEE
Want to see VSEE full AI Analyst Report?
VSEE Stock Chart & Stats
$0.38
-$0.02(-1.82%)
At close: 4:00 PM EST
$0.38
-$0.02(-1.82%)
Day’s Range― - ―
52-Week Range$0.15 - $2.52
Previous CloseN/A
Volume71.92K
Average Volume (3M)1.90M
Market Cap
$8.85M
Enterprise Value$3.28M
Total Cash (Recent Filing)$1.35M
Total Debt (Recent Filing)$1.66M
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Sep 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding48,599,422
10 Day Avg. Volume5,577,105
30 Day Avg. Volume1,899,699
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap0.37
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit0.49
Enterprise Value/Ebitda-0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.24
Revenue Forecast (FY)$21.60M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelVSee's mix of subscription platform fees, professional services, and ongoing support creates recurring and contractually-backed revenue. These elements raise switching costs and drive customer stickiness across provider organizations, supporting more predictable revenue as telehealth programs scale.
Improved Leverage / Balance-sheet PositioningA reduced debt burden (debt-to-equity ~0.26) and lower absolute debt versus 2024 improve financial flexibility and reduce insolvency risk. This positioning gives management runway to execute growth or margin initiatives and lowers the near-term probability of distress financing.
Demand / Improving Cash MetricsReported revenue growth (~18%) alongside improvement in free cash flow versus the prior year signals sustained market demand and early operational leverage. If this trend persists, it supports durable scaling of the platform and reduces the pace of required external funding over a multi-month horizon.
Bears Say
Large Operating And Net LossesTTM operating margin near -60% and severe net losses (~-92%) show the business remains far from break-even. Persistent deep losses constrain reinvestment, depress returns on capital, and require continued external funding unless management achieves material margin improvement.
Negative Cash Flow / Cash BurnMaterial negative operating and free cash flow (~-$5.5M TTM) indicate ongoing cash burn that shortens runway for a small operator. Continued outflows increase dependence on financing, limit strategic optionality, and raise execution risk over the next several months absent sustained FCF improvement.
Significant Dilution RiskApproval to issue up to 19.67M shares tied to warrants creates substantial dilution potential. While this provides financing flexibility, the scale of authorized issuance can materially dilute existing holders and weaken per-share economics, signaling reliance on equity solutions for capital needs.
VSee Health News
VSEE FAQ
What was VSee Health’s price range in the past 12 months?
VSee Health lowest stock price was $0.14 and its highest was $2.52 in the past 12 months.
What is VSee Health’s market cap?
VSee Health’s market cap is $8.85M.
When is VSee Health’s upcoming earnings report date?
VSee Health’s upcoming earnings report date is Sep 28, 2026 which is in 121 days.
How were VSee Health’s earnings last quarter?
Currently, no data Available
Is VSee Health overvalued?
According to Wall Street analysts VSee Health’s price is currently Overvalued.
Does VSee Health pay dividends?
VSee Health does not currently pay dividends.
What is VSee Health’s EPS estimate?
VSee Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VSee Health have?
VSee Health has 48,599,422 shares outstanding.
What happened to VSee Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VSee Health?
Currently, no hedge funds are holding shares in VSEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VSee Health
VSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Technical Analysis
Ownership Overview
11.34% Insiders
0.58% Mutual Funds
7.47% Other Institutional Investors
80.17% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---